Benitec Biopharma Inc

BNTC14 Dec 2024
Healthcare
$12.45
-0.05 (-4.70%)
Lowest Today
$11.36
Highest Today
$12.64
Today’s Open
$12.45
Prev. Close
$12.35
52 Week High
$13.22
52 Week Low
$2.69
To Invest in Benitec Biopharma Inc

Benitec Biopharma Inc

Healthcare
BNTC14 Dec 2024
-0.05 (-4.70%)
1M
3M
6M
1Y
5Y
Low
$11.36
Day’s Range
High
$12.64
11.36
52 Week Low
$2.69
52-Week Range
52 Week High
$13.22
2.69
1 Day
-
1 Week
+3.89%
1 month return
+21.65%
3 month return
+48.98%
6 month return
+75.49%
1 Year return
+309.47%
3 Years return
-75.18%
5 Years return
-90.15%
10 Years return
-
Institutional Holdings
Suvretta Capital Management, LLC
38.03
Franklin Biotechnology Discv A(acc)USD
7.07
HHG PLC
3.78
Adage Capital Partners Gp LLC
3.62
Nantahala Capital Management, LLC
3.61
Franklin Resources Inc
3.43
Awm Investment Company Inc
2.69

Market Status

Fundamentals
Market Cap
215.39 mln
PB Ratio
4.47
PE Ratio
0
Enterprise Value
236.04 mln
Total Assets
52.21 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. Benitec Biopharma Inc. was incorporated in 1995 and is headquartered in Hayward, California.
Organisation
Benitec Biopharma Inc
Employees
16
Industry
Biotechnology
CEO
Dr. Jerel A. Banks M.D., Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities